« Back
Home /
Ipilimumab (anti-CTLA-4)

Ipilimumab (anti-CTLA-4)

Item no.	A2001-5
Manufacturer	Selleckchem
CASRN	477202-00-9
Amount	1mg x 5
Quantity options	1mg 20 mg 1mg x 25 1mg x 5
Category	Oncology Antibodies By Cell Type Carcinoma Primary Antibodies
Type	Antibody
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	MDX-010, BMS-734016
Available
Manufacturer - Targets	CD152
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg x 5

available

Delivery expected until 1/10/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail